The term “polypharmacy” has been around since the 1700s, but it’s only recently that it’s taken on a deeply negative connotation. Unfortunately, that connotation is warranted. “Overtreatment” with medically unnecessary drugs is a real problem in America and even around the world. It’s important to understand that polypharmacy isn’t a member or patient problem. It’s not a provider problem. It’s not even a pharmacy problem. It’s a problem that belongs to all of us in the healthcare industry, which is why we need to address it together. So, although last year we wrote about polypharmacy and emphasized the role of analytics in solving it, today we want to think bigger than that. If we want to really solve it, we’ll have to use analytics the way it was intended – leveraged as a powerful tool in a systematic approach.
Want to talk about how we do this? So do we.